Literature DB >> 31366312

Cannabis and Cannabinoid Biology in Stroke.

Sang-Ho Choi1,2, Yongshan Mou1,2, Afonso C Silva1,2.   

Abstract

Entities:  

Keywords:  brain ischemia; cannabidiol; dronabinol; humans; nervous system diseases

Mesh：

Substances：

Year:  2019        PMID： 31366312      PMCID： PMC6713285          DOI： 10.1161/STROKEAHA.118.023587

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  61 in total

1.  Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.

Authors:  Andrew I R Maas; Gordon Murray; Herbert Henney; Nadim Kassem; Valerie Legrand; Miriam Mangelus; Jan-Paul Muizelaar; Nino Stocchetti; Nachshon Knoller
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

2.  The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines.

Authors:  David Panikashvili; Na'ama A Shein; Raphael Mechoulam; Victoria Trembovler; Ron Kohen; Alexander Alexandrovich; Esther Shohami
Journal:  Neurobiol Dis       Date:  2005-12-20       Impact factor: 5.996

3.  Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism.

Authors:  Kenichi Mishima; Kazuhide Hayakawa; Kohji Abe; Tomoaki Ikeda; Nobuaki Egashira; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Stroke       Date:  2005-04-21       Impact factor: 7.914

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Increased severity of stroke in CB1 cannabinoid receptor knock-out mice.

Authors:  Sophie Parmentier-Batteur; Kunlin Jin; Xiao Ou Mao; Lin Xie; David A Greenberg
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

6.  Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; Viktor R Drel; Irina G Obrosova; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-23       Impact factor: 4.733

7.  Cognitive functioning of long-term heavy cannabis users seeking treatment.

Authors:  Nadia Solowij; Robert S Stephens; Roger A Roffman; Thomas Babor; Ronald Kadden; Michael Miller; Kenneth Christiansen; Bonnie McRee; Janice Vendetti
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

8.  The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets.

Authors:  Engelbert Deusch; Hans Georg Kress; Birgit Kraft; Sibylle A Kozek-Langenecker
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

9.  Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.

Authors:  Kazuhide Hayakawa; Kenichi Mishima; Masanori Nozako; Mai Hazekawa; Ayumi Ogata; Masayuki Fujioka; Kazuhiko Harada; Shohei Mishima; Kensuke Orito; Nobuaki Egashira; Katunori Iwasaki; Michihiro Fujiwara
Journal:  Life Sci       Date:  2007-01-19       Impact factor: 5.037

10.  Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210.

Authors:  Ronen R Leker; Naomi Gai; Raphael Mechoulam; Haim Ovadia
Journal:  Stroke       Date:  2003-06-26       Impact factor: 7.914
View more
  6 in total

Review 1.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 2.  The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Joseph Bryant; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2021-08-31       Impact factor: 6.208

Review 3.  Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection.

Authors:  Andrés Vicente-Acosta; Maria Ceprian; Pilar Sobrino; Maria Ruth Pazos; Frida Loría
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 4.  Cannabis and Inflammation in HIV: A Review of Human and Animal Studies.

Authors:  Ronald J Ellis; Natalie Wilson; Scott Peterson
Journal:  Viruses       Date:  2021-08-02       Impact factor: 5.048

5.  Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients.

Authors:  Rosaria Greco; Chiara Demartini; Annamaria Zanaboni; Elena Tumelero; Candeloro Elisa; Alessandra Persico; Andrea Morotti; Diana Amantea; Cristina Tassorelli
Journal:  Transl Stroke Res       Date:  2020-09-22       Impact factor: 6.829

6.  Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.

Authors:  Arsene Zongo; Cerina Lee; Jason R B Dyck; Jihane El-Mourad; Elaine Hyshka; John G Hanlon; Dean T Eurich
Journal:  BMC Cardiovasc Disord       Date:  2021-09-10       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.